期刊文献+

类风湿性关节炎患者CXC趋化因子配体16表达及临床意义 被引量:5

The expression of CXCL16 and its clinical significance in patients with rheumatoid arthritis
原文传递
导出
摘要 目的探讨类风湿关节炎(RA)患者血清CXC趋化因子配体16(CXCL16)水平变化及临床意义。方法采用酶联免疫吸附法(ELISA)检测200例RA患者(RA组)、180例骨关节炎患者(OA组)及200例健康体检者(正常对照组)血清CXCL16水平,比较组间CXCL16水平差异;根据关节疾病活动度评分(DAS28),将RA组分为高度活动组、中度活动组和低度活动组,比较组间CXCL16水平差异,并分析DAS28评分与CXCL16水平的相关性。结果 RA组血清CXCL16水平明显高于OA组和正常对照组,差异有统计学意义(P<0.05);OA组与正常对照组之间CXCL16水平差异无统计学意义(P>0.05);RA高度活动组、中度活动组和低度活动组之间CXCL16水平差异有统计学意义(P<0.05)。各组CXCL16水平与DAS28评分均呈正相关(r值分别为0.820、0.674、0.748,P<0.01)。结论血清CXCL16可作为RA的实验室诊断指标,也可作为病情观察和预后判断的依据。 Objective To discuss the changing levels of serum CXC chemokine ligand 16( CXCL16) in patients with rheumatoid arthritis( RA) and its clinical significance. Methods Using enzyme- linked immunosorbent assay( ELISA),we measured the concentration of serum CXCL16 in 200 patients with RA( RA group),180 patients with osteoarthritis patients( OA group)and 200 healthy persons( normal control group),their different levels of CXCL16 were compared among the groups. According to the joint disease activity score( DAS28),RA group was divided into the high activity group,moderate activity group and low activity group,the different CXCL16 levels were compared among these groups,and we analyzed the correlation between DAS28 score and CXCL16 level. Results The level of serum CXCL16 in RA group was significantly higher than that in OA group and normal control group,and the difference had statistical significance( P〈0. 05); the level difference of CXCL16 between OA group and normal control group was not statistically significant( P〈0. 05). In RA group,there was no statistical significance on the difference of CXCL16 levels of high activity group,moderate activity group and low activity group( P〈0. 05). CXCL16 level and DAS28 score were positively correlated in each group( r = 0. 820,0. 674,0. 748,P〈0. 01). Conclusion Serum CXCL16 can be used as laboratory index in the diagnosis of RA,which can also be used as the observation and prognosis judgment basis.
作者 孙安民 王伟
出处 《中国卫生检验杂志》 CAS 2015年第17期2922-2923,2927,共3页 Chinese Journal of Health Laboratory Technology
关键词 类风湿关节炎 CXC趋化因子配体16 相关性分析 临床意义 Rheumatoid arthritis CXC chemokine ligand 16 Correlation analysis Clinical significance
  • 相关文献

参考文献8

  • 1孙宁,诸葛欣,王丽莉,陈翊玲,张蕴.老年急性冠脉综合征患者CXCL16与血管新生的关系[J].河北医药,2012,34(10):1451-1452. 被引量:2
  • 2孙琳,刘蕊,刘湘源,赵金霞,徐宁,龙丽,栗占国.类风湿关节炎患者外周血CXCL16的表达及临床意义[J].北京大学学报(医学版),2010,42(5):591-592. 被引量:2
  • 3Van der Heijde DM, Van't Hof M, Van Riel PL, et al. Develop- ment of a disease activity score based on judgment in clinical prac- tice by rheumatologists [ J ]. J Rheumatol, 1993, 20 ( 3 ) : 579 - 581.
  • 4Matloubian M, David A, Engel S, et al. A transmembrane CXC chemokine is a ligand for HIV coreceptor Bonzo[ J]. Nat Immunol, 2000, 1(4) : 298 -304.
  • 5Wilbanks A, Zondlo SC, Mushy K, et al. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC and CX3C ehemokines[ J ]. J Immunol, 2001, 166 ( 8 ) : 5145 - 5154.
  • 6满斯亮,孙琳,赵金霞,刘湘源.CXCL10和CXCL16在胶原诱导性关节炎大鼠外周血中的测定及意义[J].山东医药,2010,50(40):28-30. 被引量:2
  • 7Nanki T, Shimaoka T, Hayashida K, et al. Pathogenic role of the CXCL16 -CXCR6 pathway in rheumatoid arthritis [ J]. Arthritis Rheum, 2005, 52(10) : 3004 -3014.
  • 8Van der Voort R, Van Lieshout AW, Toonen LW, et al. Elevated CXCL16 expression by synovial maerophages recruits memory T cells into rheumatoidjoints [ J ]. Arthritis Rheum, 2005, 52 ( 5 ) : 1381 -1391.

二级参考文献23

  • 1Sheikine Y,Sirsjo A.CXCL16/SR-PSOX-A friend or a foe in atherosclerosis[J]?Atherosclerosis,2008,197(2):487-495.
  • 2Ruth JH,Haas CS,Park CC,et al.CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MARK pathway[J].Arthrtis Rheum,2006,54(3):765-778.
  • 3van der Heijde DM,van't Hof M,van Riel PL,et al.Development of a disease activity score based on judgment in clinical practice by rheumatologists[J].J Rheumatol,1993,20(3):579-581.
  • 4Matloubian M,David A,Engels,et al.A transmembrane CXC chemokine is a ligand for HIV coreceptor Bonzo[J].Nat Immunol,2000,1(4):298-304.
  • 5Wilbanks A,Zondlo SC,Murphy K,et al.Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC,CXC and CX3C chemokines[J].J Immunol,2001,166(8):5145-5154.
  • 6Abel S,Hundhausen C,Mentlein R,et al.The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNFalpha and shed by the activity of the disintegrin-like metalloproteinase ADAM 10[J].J Immunol,2004,172(10):6362-6372.
  • 7Nanki T,Shimaoka T,Hayashida K,et al.Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis[J].Arthritis Rheum,2005,52(10):3004-3014.
  • 8Kageyama Y,Torikai E,Nagano A.Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis[J].Rheumatol Int,2007,27(5):467-472.
  • 9van der Voort R,van Lieshout AW,Toonen LW,et al.Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints[J].Arthritis Rheum,2005,52(5):1381-1391.
  • 10van Lieshout AW,van der Voort R,Toonen LW,et al.Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis[J].Ann Rheum Dis,2009,68(6):1036-1043.

共引文献3

同被引文献80

  • 1Weaver CT,Hatton RD,Mangan PR,et al.IL-17 family cytokines and the expanding diversity of effector T cell lineages [ J ] .Annu Rev Immunol,2007 ( 25 ) :821-852.
  • 2Lubberts E.IL-17/Th17 targeting:on the road to prevent chronic destructive arthritis? [J].Cytokine,2008,41 ( 2 ) :84-91.
  • 3Wilburn J,McKenna S P,Twiss J,et al.Further international adaptationand validation of the Rheumatoid Arthritis Quality of Life ( RAQoL) questionnaire[J].Rheumatol Int,2015,35(4):669-675.
  • 4Katumba J,Obore S,Kaye D K.Health-related quality of life among patients with ovarian cancer at Mulago Hospital,Uganda[J].Int J Gynaecol Obstet,2013,122(2):115-117.
  • 5Kupfer P,Huber R,Weber M,et al.First-time application of multi-stimuli network inference to synovial fibroblasts of rheumatoid arthritis patients[J].BMC Med Genomics,2014,7(1):40.
  • 6Nagai N,Ito Y.Effect of solid nanoparticle of indomethacin ontherapy for rheumatoid arthritis in adjuvant-induced arthritis rat[J].Biol Pharm Bull,2014,37(7):1109-1118.
  • 7张晓岚,蒋兴亮,邢艳,刘素兰,张均,王光华,罗书久.类风湿关节炎患者血浆对氧磷酯酶-1活性与氧自由基代谢水平的相关性研究[J].检验医学,2009,24(7):502-505. 被引量:8
  • 8逯惠敏,付琳,蒋红梅,胡晓蕾.类风湿性关节炎患者氧化应激状态的检测[J].贵州医药,2009,33(9):832-833. 被引量:3
  • 9周彩云,王鑫,潘峥,唐今扬.类风湿关节炎中医辨治研究进展[J].北京中医药,2010,29(4):314-317. 被引量:1
  • 10类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270. 被引量:1309

引证文献5

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部